Rx Processing Corp. Announces Shareholders Meeting November 7th, 2006 Wednesday September 20, 9:05 pm ET
WILMINGTON, Del.--(BUSINESS WIRE)--Sept. 20, 2006--Rx Processing Corporation (OTC:RXPC - News) announces shareholders meeting to launch our phase II storefront and ordering technology, November 7th, 2006. ADVERTISEMENT
Rx Processing Corp, shareholder meeting to be held at 745 New Hampshire St. Suite 8B, Lawrence, Kansas, November 7th, 2006. Shareholders attending are asked to call corporate at 800-576-7055 to confirm their presence. All shareholders will be mailed meeting schedule information, convenient lodging locations and airport directions. Attendees will be able to review our corporate financial pro-forma and structured business plan while we conduct shareholder business for the corporation.
"Whereas affordable health care was once thought of as an impossible mission a few years ago, I see long term success in sustainable processing a reality today," says Peter Fiorillo, CEO, Rx Processing Corp. "As an advocate and innovator, we recognize that a Wall Street Journal article on August 2nd, 2006 has generated and increased corporate awareness of Rx Processing Corp. by communicating its focus on corporate advocacy. This awareness has contributed to the knowledge, trust, and basis of confidence building amongst clients, shareholders, and the marketplace."
O/S: 55,883,577
Float: 21,744,502
About Rx Processing Corp.
Rx Processing Corp. is innovating storefront and online ordering technology for the distribution of pharmaceutical medications and Laboratory diagnostics managed at storefront locations in a direct to consumer delivery business model for underinsured and uninsured U.S. citizen's health care needs. Our technology platform services needy U.S. Citizens with a new RxPC Advocates program, Independent pharmacy Support service, and corporation friendly ordering system of laboratory testing and prescription medication through licensed pharmacies in the United States and CLIA-certified patient service centers. The company provides access to FDA approved brand-name and generic medications and thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 47 million United States citizens would benefit from the company's programs.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e., operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.
Market Data 
Markets 
AI
